Company profile: Leica Microsystems
1.1 - Company Overview
Company description
- Provider of precision optics systems and microscopy for microscopic imaging, measurement, and analysis. Offerings include compound and stereo microscopes, digital microscopy, confocal laser scanning and super-resolution microscopes, surgical microscopy, imaging systems, and electron microscopy sample preparation instruments.
Products and services
- Confocal Laser Scanning Microscopy: Research-grade laser-scanning instruments that produce high-resolution images of samples, enabling microscopic imaging, measurement, and analysis of microstructures across varied scientific applications
- Compound and Stereo Microscopy: Laboratory-grade light microscopes and stereomicroscopes architected for detailed microstructure analysis in diverse scientific fields, supporting precise microscopic imaging, measurement, and analysis
- Surgical Microscopy: Clinical-grade microscopes created for use in various surgical procedures to deliver enhanced visualization, supporting microscopic imaging, measurement, and analysis during surgical procedures
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Leica Microsystems
Sirnaomics
HQ: United States
Website
- Description: Provider of RNA interference-based therapeutics and delivery platforms. Develops STP705, an siRNA targeting TGF-β1 and COX-2 for non-melanoma skin cancer, cholangiocarcinoma, and hypertrophic scars; RNAi prophylactics and therapeutics for severe acute respiratory infection caused by 2019-nCoV; and delivery technologies including a polypeptide nanoparticle platform for mRNA vaccines/therapeutics and a GalNAc platform for liver-targeted RNAi.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Sirnaomics company profile →
PDS Biotech
HQ: United States
Website
- Description: Provider of the Versamune® T cell activating platform that stimulates immune responses to cancer-specific proteins, and a pipeline of subcutaneous investigational immunotherapies: Versamune® HPV (Phase 2), PDS0102 (TARP), PDS0103 (MUC1), PDS0104 (TRP2-positive melanoma), and PDS01ADC, an IL-12 fused antibody-drug conjugate enhancing T cell activity, in preclinical and clinical programs.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full PDS Biotech company profile →
Nanostellar
HQ: United States
Website
- Description: Provider of nano-engineered, precious-metals-containing catalyst materials for automotive and stationary power industries, improving emissions control and energy efficiency, reducing exhaust emissions, and enabling compliance with stringent diesel emissions requirements in Europe, the U.S., and Asia, with applications in the synthesis of chemicals and fuels.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Nanostellar company profile →
Nuformix
HQ: United Kingdom
Website
- Description: Provider of pharmaceutical products developed using cocrystal technology in the United Kingdom, leveraging world-class capability and know-how in cocrystal discovery and development to yield multiple product opportunities with an accompanying intellectual property portfolio.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Nuformix company profile →
Manhattan Scientifics
HQ: United States
Website
- Description: Provider of nanomedicine technology transfer and commercialization, including nanostructured metals that enhance strength and biocompatibility for medical devices; Magnetic Relaxometry cancer detection using superparamagnetic nanoparticles and sensitive magnetic detectors to identify and locate early-stage cancers; and MicroFuel Cell technology for 'always on' portable power in small electronics.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Manhattan Scientifics company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Leica Microsystems
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Leica Microsystems
2.2 - Growth funds investing in similar companies to Leica Microsystems
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Leica Microsystems
4.2 - Public trading comparable groups for Leica Microsystems
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →